The Effect of Levcromakalim Infusion on the Cranial Arteries Over Several Hours Using a High Resolution MRA Technique in a Randomized, Double-blind Placebo-controlled Design in Healthy Volunteers.

NCT03609008 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Dilatation of Cranial Arteries; MMA, STA and MCA
Headache

Interventions

DRUG: Levcromakalim
DRUG: Saline

Sponsor

Danish Headache Center